Eli Lilly (LLY) emerges among the top performers in Big Pharma in 2024 with obesity drug success, while Novo Nordisk (NVO) ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 500.39% and ...

If you're too busy to keep monitoring your stock portfolio every other day, then investing in stocks that won't cause you a ...

The Carroll County Community Foundation is pleased to announce the recipient of the 2025 Lilly Endowment Community ...

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Alzheimer's, addiction, cardiovascular diseases, kidney disorders, sleep apnoea, diabetes, obesity, and overweight.

A specific class of anti-inflammatory drugs can help children avoid a debilitating complication of Crohn's disease, a new ...

georgina sex Blockbuster psoriasis drugs were quickly approved, Eli Lilly, Novartis, and Johnson & Johnson staged a "Three Kingdoms" After spending tens of billions of dollars, AI doctor still failed!

wingo tool Eli Lilly's "cancer-free" RET inhibitor clinical data officially published in NEJM Well-known pharmaceutical companies respond to investigation of medical representatives Merck's SGLT-2 ...

Eli Lilly has chalked up another regulatory approval for its anti-amyloid therapy for Alzheimer's disease, Kisunla, in China – the world's second-largest pharma market. The National Medical ...

The fight against obstructive sleep apnea (OSA) has taken a monumental leap forward. For the first time, the U.S. Food and ...